Coenzyme_a
CAS 85-61-0
Coenzyme_a (CAS 85-61-0) is a Phase 3 pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 40191.666666666664 nM | 6 | - |
| - | Ki | 27126.666666666668 nM | 3 | - |
| - | EC50 | 1 10^3nM | 1 | - |
| - | Kd | 156 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Coenzyme_a used for in pharmaceutical contexts?
Coenzyme_a (CAS 85-61-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Coenzyme_a?
No adverse-event association or SIDER side-effect rows are rendered for Coenzyme_a in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Coenzyme_a also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Coenzyme A with EU status "permitted".
What clinical phase is Coenzyme_a in?
Coenzyme_a is rendered with ChEMBL max phase 3.